FDA OKs MRI-compatible pacemaker technology

The FDA approved a pacemaker system that allows the patient to undergo MR imaging scans with a limited exclusion zone.

Biotronik announced that it received FDA approval for its Entovis pacemaker system with ProMRI technology. The approval applies to single- and dual-chamber pacemakers implanted with Setrox leads. The devices were already commercially available in the U.S. but not approved for use in the MRI environment.

The FDA based its decision on a clinical study that was expanded to include full-body MRI scans. These studies evaluated the safety and efficacy of existing single- and dual-chamber Entovis pacemaker systems and Setrox 53 and 60cm leads during MRI scans.

Berlin-based Biotronik also is evaluating its ProMRI technology in implantable cardioverter-defibrillator devices.

Candace Stuart, Contributor

Around the web

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.

Kate Hanneman, MD, explains why many vendors and hospitals want to lower radiology's impact on the environment. "Taking steps to reduce the carbon footprint in healthcare isn’t just an opportunity," she said. "It’s also a responsibility."

Trimed Popup
Trimed Popup